- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03470142
The Comparison Between Traditional Laparoscopy-assisted Surgery and NOSES in Radical Resection of Colorectal Cancer
September 23, 2019 updated by: Dong Yang
The Comparison Between Traditional Laparoscopy-assisted Surgery and Total Laparoscopic Surgery With no Incision (Natural Orifice Transluminal Endoscopic Surgery,NOSES) in Radical Resection of Colorectal Cancer
This study is to compare the short-term and long-term outcomes of traditional laparoscopy-assisted surgery and total laparoscopic surgery with no incision (natural orifice transluminal endoscopic surgery, NOSES) for colorectal cancer and to find a better surgical method for patients.
Study Overview
Status
Unknown
Conditions
Study Type
Interventional
Enrollment (Anticipated)
158
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
JI Lin
-
Ch'ang-ch'un, JI Lin, China, 130021
- Recruiting
- The First Hospital of Jilin University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All cases should be diagnosed as rectal or sigmoid colon cancer by histology or cytology. The tumor is 5-20cm from the pectinate line. The clinical stage is T1-2, N0, M0 for rectal cancer and T1-T3, N0-2, M0 for sigmoid colon cancer.
- Eastern Cooperative Oncology Group (ECOG) scale 0-2
- Heart, lung, liver, and kidney function can tolerate operation
- Patients and their families are able to understand and be willing to participate in this clinical study and to sign informed consent.
Exclusion Criteria:
- history of colorectal malignant disease
- recent diagnosis of other malignant tumors (except for papillary carcinoma of the thyroid gland and basal cell carcinoma of the skin)
- patients with intestinal obstruction, intestinal perforation, bleeding requiring emergency surgery
- a history of abdominal surgery (which makes it difficult to perform laparoscopic procedures), severe systemic disease such as diabetes, severe chronic lung disease, cirrhosis, other malignant diseases
- combined colorectal multiple carcinomas
- poor anal function before operation and incontinence of defecation
- with a history of serious mental illness
- pregnant or lactating women
- The researchers believe that the patients are unsuitable to participate in the researchers with other cases. A patient or family refusal to join
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: traditional laparoscopy-assisted surgery
The traditional laparoscopic operation undergo and then a small incision(5cm) is made in the middle of the lower abdominal wall to trim the mesangial membrane and remove the specimen.
At last the anastomosis operation undergo by the laparoscopic operation.
|
All surgical procedures will be performed by the surgery team ,which is leaded by professor Sun Dong-Hui and Wang Quan.
The traditional laparoscopic operation undergo and then a small incision(5cm) is made in the middle of the lower abdominal wall to trim the mesangial membrane and remove the specimen.
At last the anastomosis operation undergo by the laparoscopic operation.
|
|
EXPERIMENTAL: total laparoscopic surgery with no incision (NOSES)
The whole procedures undergo by total laparoscopic surgery with no incision in the abdominal wall.
The specimen then will be removed through natural orifice such as anal.
|
All surgical procedures will be performed by the surgery team ,which is leaded by professor Sun Dong-Hui and Wang Quan.
The whole procedures undergo by total laparoscopic surgery with no incision in the abdominal wall.
The specimen then will be removed through natural orifice (anal).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the incidence of complications
Time Frame: one month after surgery
|
All postoperative complications in the perioperative period will be classified by the Clavien-Dindo classification.The classification mainly focuses on the medical perspective, with major emphasis on the risk and invasiveness of the therapy used to correct a complication.
From light to heavy, it consists of five grades (Ⅰ to Ⅴ)
|
one month after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the operation time
Time Frame: in the perioperative period
|
The descriptive name of unit would be minute (min).
|
in the perioperative period
|
|
the blood loss during the operation
Time Frame: in the perioperative period
|
The descriptive name of unit would be millilitre (ml).
|
in the perioperative period
|
|
Postoperative recovery of intestinal peristalsis
Time Frame: in the perioperative period
|
The descriptive name of unit would be hour (h).
|
in the perioperative period
|
|
Visual Analogue Scale/Score
Time Frame: in the perioperative period
|
A Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured.It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms.For example, the amount of pain that a patient feels ranges across a continuum from none to an extreme amount of pain ( from 0 to 10).
|
in the perioperative period
|
|
the functional outcome of defecation, if there is incontinence
Time Frame: Three months after operation
|
Anal incontinence was evaluated using the Wexner Continence Grading Scale , the score being calculated after the patients' completion of a daily defecatory questionnaire.
Range is from 0 (normal continence) to 20 (maximum incontinence with maximum disturbance of lifestyle).
|
Three months after operation
|
|
3-year disease-free survival
Time Frame: three years after operation
|
three years after operation
|
|
|
cases converted to laparotomy
Time Frame: in the perioperative period
|
The procedure for cases who underwent laparoscopy-assisted surgery or NOSES can not go successfully, and then it will be converted to laparotomy.
The number of all those cases should be recorded.
|
in the perioperative period
|
|
The mean postoperative hospital stay
Time Frame: in the perioperative period
|
The descriptive name of unit would be day (d).
|
in the perioperative period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Dong-Hui Sun, Doctor, The First Hospital of Jilin University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 20, 2018
Primary Completion (ANTICIPATED)
March 20, 2020
Study Completion (ANTICIPATED)
March 20, 2022
Study Registration Dates
First Submitted
March 4, 2018
First Submitted That Met QC Criteria
March 12, 2018
First Posted (ACTUAL)
March 19, 2018
Study Record Updates
Last Update Posted (ACTUAL)
September 24, 2019
Last Update Submitted That Met QC Criteria
September 23, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 130001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
There is no plan to make individual participant data (IPD) available to other researchers.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Laparoscopy-assisted Surgery
-
Seger Surgical SolutionsRecruitingLaparoscopy-assisted Surgery | Anastomosis, Surgical | Gastrointestinal Surgical Procedures | EnterotomyEl Salvador
-
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training...CompletedSurgery | Hysterectomy | LaparoscopyTurkey
-
San Giovanni di Dio HospitalRecruitingLaparoscopy | Abdominal Surgery by LaparotomyItaly
-
Klinik für Allgemein- und Viszeralchirurgie, Department...WithdrawnLaparoscopy Training | Robotic Surgery TrainingSwitzerland
-
Northwestern UniversityWithdrawnLaparoscopy | Gynecologic Surgery | Quality of RecoveryUnited States
-
Seoul St. Mary's HospitalMerck Sharp & Dohme LLCCompletedLaparoscopic Renal Surgery | Laparoscopy | Muscle RelaxationKorea, Republic of
-
University Hospital, GrenobleSuspendedMaxillofacial Surgery | Computer-Assisted SurgeryFrance
-
Istanbul University - CerrahpasaRecruitingGeneral Anesthesia | Video-assisted Thoracoscopic Surgery (VATS) | Postoperative Recovery | Thoracic Surgery, Video Assisted | Anesthesia TechniquesTurkey (Türkiye)
-
Sunnybrook Health Sciences CentreUnknownComputer-assisted Surgery
-
Sunnybrook Health Sciences CentreUnknownComputer-assisted Surgery
Clinical Trials on traditional laparoscopy-assisted surgery
-
The University of Texas Health Science Center,...CompletedSterility, FemaleUnited States
-
Intuitive SurgicalWithdrawn
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Renal Cell Cancer | Stage I Renal Cell Cancer | Stage II Renal Cell CancerUnited States
-
University of FloridaCompletedPancreas Disease | Biliary DiseaseUnited States
-
Beijing Jishuitan HospitalNot yet recruitingRecurrent Patellar Dislocation | Osteotomy | Patellar Maltracking
-
City of Hope Medical CenterWithdrawnRecurrent Rectal Cancer | Stage I Rectal Cancer | Stage II Rectal Cancer | Stage III Rectal Cancer
-
Tampere University HospitalUnknown
-
Beijing Jishuitan HospitalUnknownPedicle Screw of Fixation
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedStage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Endometrial Adenocarcinoma | Stage I Uterine Sarcoma | Stage II Uterine SarcomaUnited States
-
WEI XUNot yet recruitingMinimally Invasive Surgery | Spinal MetastasesChina